Acta Dermato-Venereologica Issue No. 97-5 97-5CompleteContent | Page 14

607 INVESTIGATIVE REPORT Mortality and Cause of Death in Patients with Pemphigus Khalaf KRIDIN 1 , Shira ZELBER-SAGI 2 and Reuven BERGMAN 1,3 1 Department of Dermatology, Rambam Health Care Campus and 2 School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, 3 Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel All-cause and cause-specific mortality among patients with pemphigus compared with the general population is yet to be established. This study investigated overall mortality and cause-specific mortality in a large immu- nopathologically validated cohort of patients with pem- phigus. Mortality of patients with pemphigus was com- pared with age- and gender-matched control subjects in the general population. All-cause and cause-specific standardized mortality ratios (SMRs) were estimated. The study cohort included 245 patients newly-diagno- sed with pemphigus between January 1990 and June 2016, contributing 2,679.4 person-years of follow-up. Overall, 48 deaths were observed during a mean fol- low-up period of 10.9  ±  8.1 years, which was more than twice the number expected (SMR 2.4; 95% confidence interval (95% CI) 1.82–3.20). The SMRs for death due to infections (22.6; 95% CI 13.6–35.3), namely pneu- monia (25.7; 95% CI 11.7–48.8) and septicaemia (8.6; 95% CI 1.7–25.0), and due to cardiovascular diseases (2.8; 95% CI 1.0–6.0) were significantly higher than expected. Overall mortality among patients with pem- phigus is 2.4-times greater than for the general popu- lation, mainly due to infections. Key words: mortality; prognosis; survival; cause of death; pemphigus, Israel. Accepted Jan 12, 2017; Epub ahead of print Jan 17, 2017 Acta Derm Venereol 2017; 97: 607–611. Corr: Khalaf Kridin, Department of Dermatology, Rambam Health Care Campus, POB 9602, Haifa 31096, Israel. E-mail: [email protected] P emphigus is a rare, chronic, potentially life-threa- tening, autoimmune blistering disease of the skin and mucous membranes. There are 2 major subtypes of pemphigus: pemphigus vulgaris (PV) and pemphigus foliaceus (PF). The aetiopathogenesis of pemphigus is characterized by acantholysis and intraepidermal blister formation, resulting from IgG autoantibodies directed against desmoglein (Dsg) 3 (PV) an